Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
Genscript Biotech (01952.HK) Major Shareholder Increases Holding by 860,000 Shares
Recommend 1 Positive 0 Negative 2 |
||||
|
||||
|
Genscript Biotech (01952.HK) announced that its Non-Executive Director, Honorary Chairman of the Board, and major shareholder, Fu Wei, purchased 860,000 ordinary shares of the company on March 27, 2026, through a company he controls. The total consideration was approximately HKD32.7 million, with an average price of about HKD38.12 per share. Fu Wei stated that the shares were acquired through on-market purchases, reflecting his firm confidence in the company's future prospects and long-term development. Subject to applicable laws and regulations, Fu Wei does not rule out the possibility of further increasing his shareholding in the company at an appropriate time. (hc/a) Auto-translated by third-party software This translation was auto-generated by third-party software. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
